The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Open accessAbstract
STUDY QUESTION: What is the recommended assessment and management of women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise and consumer preference? SUMMARY ANSWER: International evidence-based guidelines, including 166 recommendations and practice points, addressed prioritized questions to promote consistent, evidence-based care and improve the experience and health outcomes of women with PCOS. WHAT IS KNOWN ALREADY: Previous guidelines either lacked rigorous evidence-based processes, did not engage consumer and international multidisciplinary perspectives, or were outdated. Diagnosis of PCOS remains controversial, and assessment and management are inconsistent. The needs of women with PCOS are not being adequately met and evidence practice gaps persist. STUDY DESIGN, SIZE, DURATION: International evidence-based guideline development engaged professional societies and consumer organizations with multidisciplinary experts and women with PCOS directly involved at all stages. Appraisal of Guidelines for Research and Evaluation (AGREE) II-compliant processes were followed, with extensive evidence synthesis. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was applied across evidence quality, feasibility, acceptability, cost, implementation and ultimately recommendation strength. PARTICIPANTS/MATERIALS, SETTING, METHODS: Governance included a six continent international advisory and a project board, five guideline development groups, and consumer and translation committees. Extensive health professional and consumer engagement informed guideline scope and priorities. Engaged international society-nominated panels included pediatrics, endocrinology, gynecology, primary care, reproductive endocrinology, obstetrics, psychiatry, psychology, dietetics, exercise physiology, public health and other experts, alongside consumers, project management, evidence synthesis and translation experts. In total, 37 societies and organizations covering 71 countries engaged in the process. Twenty face-to-face meetings over 15 months addressed 60 prioritized clinical questions involving 40 systematic and 20 narrative reviews. Evidence-based recommendations were developed and approved via consensus voting within the five guideline panels, modified based on international feedback and peer review, with final recommendations approved across all panels. MAIN RESULTS AND THE ROLE OF CHANCE: The evidence in the assessment and management of PCOS is generally of low to moderate quality. The guideline provides 31 evidence based recommendations, 59 clinical consensus recommendations and 76 clinical practice points all related to assessment and management of PCOS. Key changes in this guideline include: (i) considerable refinement of individual diagnostic criteria with a focus on improving accuracy of diagnosis; (ii) reducing unnecessary testing; (iii) increasing focus on education, lifestyle modification, emotional wellbeing and quality of life; and (iv) emphasizing evidence based medical therapy and cheaper and safer fertility management. LIMITATIONS, REASONS FOR CAUTION: Overall evidence is generally low to moderate quality, requiring significantly greater research in this neglected, yet common condition, especially around refining specific diagnostic features in PCOS. Regional health system variation is acknowledged and a process for guideline and translation resource adaptation is provided. WIDER IMPLICATIONS OF THE FINDINGS: The international guideline for the assessment and management of PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences. Research recommendations have been generated and a comprehensive multifaceted dissemination and translation program supports the guideline with an integrated evaluation program. STUDY FUNDING/COMPETING INTEREST(S): The guideline was primarily funded by the Australian National Health and Medical Research Council of Australia (NHMRC) supported by a partnership with ESHRE and the American Society for Reproductive Medicine. Guideline development group members did not receive payment. Travel expenses were covered by the sponsoring organizations. Disclosures of conflicts of interest were declared at the outset and updated throughout the guideline process, aligned with NHMRC guideline processes. Full details of conflicts declared across the guideline development groups are available at https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline in the Register of disclosures of interest. Of named authors, Dr Costello has declared shares in Virtus Health and past sponsorship from Merck Serono for conference presentations. Prof. Laven declared grants from Ferring, Euroscreen and personal fees from Ferring, Euroscreen, Danone and Titus Healthcare. Prof. Norman has declared a minor shareholder interest in an IVF unit. The remaini
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such weight management strategies should encompass multidisciplinary lifestyle interventions, comprising of dietary, exercise and behavioural therapies [10].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although moderate certainty evidence also suggests that metformin results in a substantially greater number of GI AEs than MI, we note that these adverse events are generally mild and self-limiting (5) and that a sensitivity analysis on studies judged to be at low risk of bias did not detect a difference between groups for GI AEs.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lifestyle interventions are first-line treatments, however attrition in women with PCOS is high.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Metformin, a biguanide that decreases hepatic glucose production and increases body insulin sensitivity, is recommended in the 2018 international evidence-based PCOS guideline (5) for management of anthropometric and metabolic outcomes in PCOS.”
The cited source says what the claim attributes to it.
In the citing paper
“Extended-release preparations may also decrease the gastrointestinal side effects.2,66”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Self-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citationBalen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Self-citationThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationGoodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dsc · Cited by 623
Self-citationGibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2963 · Cited by 428
Self-citation
Cited by
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad463 · Cited by 946
Self-citationJoham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Self-citationUpdate on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Self-citationTeede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad096 · Cited by 525
Self-citationPolycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525
Metadata
- Authors
- Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., Azziz, R., Balen, A., Baye, E., Boyle, J., Brennan, L., Broekmans, F., Dabadghao, P., Devoto, L., Dewailly, D., Downes, L., Fauser, B., Franks, S., Garad, R. M., Gibson-Helm, M., Harrison, C., Hart, R., Hawkes, R., Hirschberg, A., Hoeger, K., Hohmann, F., Hutchison, S., Joham, A., Johnson, L., Jordan, C., Kulkarni, J., Legro, R. S., Li, R., Lujan, M., Malhotra, J., Mansfield, D., Marsh, K., McAllister, V., Mocanu, E., Mol, B. W., Ng, E., Oberfield, S., Ottey, S., Peña, A., Qiao, J., Redman, L., Rodgers, R., Rombauts, L., Romualdi, D., Shah, D., Speight, J., Spritzer, P. M., Stener-Victorin, E., Stepto, N., Tapanainen, J. S., Tassone, E. C., Thangaratinam, S., Thondan, M., Tzeng, C.-R., van der Spuy, Z., Vanky, E., Vogiatzi, M., Wan, A., Wijeyaratne, C., Witchel, S., Woolcock, J., & Yildiz, B. O.
- Affiliations
- Monash Health (AU)
- UNSW Sydney (AU)
- University of Pennsylvania (US)
- Erasmus MC (NL)
- Oulu University Hospital (FI)
- National Health and Medical Research Council (AU)
- Odense University Hospital (DK)
- State University of New York (US)
- Leeds Teaching Hospitals NHS Trust (GB)
- Monash Centre for Health Research and Implementation, Australia
- Australian Catholic University (AU)
- University Medical Center Utrecht (NL)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Université de Lille (FR)
- Imperial College London (GB)
- Monash University (AU)
- Monash University, Australia
- The University of Western Australia (AU)
- Karolinska Institutet (SE)
- University of Rochester (US)
- Victorian Assisted Reproductive Treatment Authority, Australia
- Monash Alfred Psychiatry Research centre (AU)
- Pennsylvania State University (US)
- Cornell University (US)
- Northside Nutrition & Dietetics, Australia
- Royal College of Surgeons in Ireland (IE)
- Columbia University Irving Medical Center (US)
- The University of Adelaide (AU)
- Peking University Third Hospital (CN)
- Pennington Biomedical Research Center (US)
- Agostino Gemelli University Polyclinic (IT)
- Deakin University (AU)
- Universidade Federal do Rio Grande do Sul (BR)
- Karolinska Institutet, Sweden
- University of Helsinki (FI)
- Queen Mary University of London (GB)
- Taipei Medical University Hospital (TW)
- University of Cape Town (ZA)
- University of Cape Town, South Africa
- Children's Hospital of Philadelphia (US)
- University of Colombo (LK)
- University of Pittsburgh (US)
- Women's and Children's Hospital (AU)
- Hacettepe University School of Medicine, Ankara, Turkey
- Corresponding author
- Teede, Helena J
- ORCID
- Teede, Helena J
- Misso, Marie L
- Costello, Michael F
- Dokras, Anuja
- Laven, Joop
- Moran, Lisa
- Piltonen, Terhi
- Norman, Robert J
- Andersen, Marianne
- Azziz, Ricardo
- Balen, Adam
- Baye, Estifanos
- Boyle, Jacqueline
- Brennan, Leah
- Broekmans, Frank
- Dabadghao, Preeti
- Dewailly, Didier
- Fauser, Bart
- Franks, Stephen
- Garad, Rhonda M
- Harrison, Cheryce
- Hart, Roger
- Hirschberg, Angelica
- Hoeger, Kathleen
- Joham, Anju
- Johnson, Louise
- Jordan, Cailin
- Kulkarni, Jayashri
- Legro, Richard S
- Li, Rong
- Lujan, Marla
- Malhotra, Jaideep
- Mansfield, Darren
- Marsh, Kate
- Mocanu, Edgar
- Mol, Ben W
- Ng, Ernest
- Oberfield, Sharon
- Ottey, Sasha
- Peña, Alexia
- Qiao, Jie
- Redman, Leanne
- Rodgers, Raymond
- Rombauts, Luk
- Romualdi, Daniela
- Shah, Duru
- Speight, Jane
- Spritzer, Poli Mara
- Stepto, Nigel
- Tapanainen, Juha S
- Tassone, Eliza C
- Thangaratinam, Shakila
- Tzeng, Chii-Ruey
- Vanky, Eszter
- Vogiatzi, Maria
- Wijeyaratne, Chandrika
- Witchel, Selma
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-07-19
- Volume
- 33
- Issue
- 9
- Pages
- 1602-1618
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- PMC
- PMC6112576
- OpenAlex
- W4212784858
- Cited by
- 1,593
- References
- 14
- Citations by year
- 2026: 163 · 2025: 215 · 2024: 208 · 2023: 249 · 2022: 241 · 2021: 216 · 2020: 170 · 2019: 114 · 2018: 15
- FWCI
- 138.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Australian National Health and Medical Research Council (APP1078444)
- European Society of Human Reproduction and Embryology
- American society for Reproductive Medicine
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, PCOS diagnosis, PCOS management, diagnostic criteria, lifestyle modification, insulin resistance, hyperandrogenism, ovulation induction, contraception, emotional well-being, patient education, customer engagement, guideline recommendations, AGREE II, GRADE, multidisciplinary consensus, quality of life
- MeSH terms
- Female, Humans, Infertility, Female, Polycystic Ovary Syndrome, Pregnancy, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. https://app.cochat.ai/papers/10.1093/humrep/dey256
- The paper
- Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., Azziz, R., Balen, A., Baye, E., Boyle, J., Brennan, L., Broekmans, F., Dabadghao, P., Devoto, L., Dewailly, D., . . . Yildiz, B. O. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction. https://doi.org/10.1093/humrep/dey256
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
